Cargando…

Providing meaningful survival benefit to hepatocellular carcinoma patients: combination therapy of future

Detalles Bibliográficos
Autor principal:	Sarkar, Devanand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577984/ https://www.ncbi.nlm.nih.gov/pubmed/36268238 http://dx.doi.org/10.21037/hbsn-22-322

Ejemplares similares

Emerging Therapies for Hepatocellular Carcinoma (HCC)
por: Chakraborty, Eesha, et al.
Publicado: (2022)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Current Status of Gene Therapy in Hepatocellular Carcinoma
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019)

New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy
por: Numata, Kauzshi, et al.
Publicado: (2022)

Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
por: Manna, Debashri, et al.
Publicado: (2020)

Meaningful Use of Pathogen Genomic Data
por: Azarian, Taj
Publicado: (2022)

Commentary on Pharmacologically Meaningful Half‐Life
por: Holford, Nick
Publicado: (2022)

Statins as Inhibitors of Lung Cancer Bone Metastasis
por: Sarkar, Devanand
Publicado: (2017)

Combination therapies for advanced hepatocellular carcinoma: a beacon of light or a castle in the air
por: Rai, Vikrant, et al.
Publicado: (2022)

Examining ways to meaningfully support students in STEM
por: Martin-Hansen, Lisa
Publicado: (2018)

Meaningful mapping of remediation in longitudinal and developmental assessment models
por: Heeneman, Sylvia, et al.
Publicado: (2020)

Molecular Mechanisms Regulating Obesity-Associated Hepatocellular Carcinoma
por: Rajesh, Yetirajam, et al.
Publicado: (2020)

Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023)

Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma Patients
por: Zhaohui, Zhang, et al.
Publicado: (2019)

From tokenism to meaningful engagement: best practices in patient involvement in an EU project
por: Supple, David, et al.
Publicado: (2015)

Approach to systemic therapy in advanced hepatocellular carcinoma
por: Sankar, Kamya, et al.
Publicado: (2022)

Towards developing a meaningful grading system for cervical squamous cell carcinoma
por: McCluggage, W Glenn
Publicado: (2018)

Meaningful use: a roadmap for the advancement of health information exchange
por: Furukawa, Michael F
Publicado: (2013)

Conventional Risk Factors Associated With Meaningful Outcomes in Advanced CKD
por: Collister, David, et al.
Publicado: (2018)

Characterizing Bilingual Effects on Cognition: The Search for Meaningful Individual Differences
por: Backer, Kristina C., et al.
Publicado: (2021)

Why do antioxidants fail to provide clinical benefit?
por: Warnholtz, Ascan, et al.
Publicado: (2000)

Combination therapy of transcatheter arterial chemoembolization with axitinib for the treatment of inoperable hepatocellular carcinoma
por: Nouso, Kazuhiro, et al.
Publicado: (2020)

Local and Regional Therapies for Hepatocellular Carcinoma and Future Combinations
por: Hatzidakis, Adam, et al.
Publicado: (2022)

Hepatocellular carcinoma therapy finds a channel on the radio
por: Camacho, Javier
Publicado: (2019)

Broken Machines or Broken Systems: The Road to Meaningful Global Radiotherapy Access
por: Elmore, Shekinah Nefreteri, et al.
Publicado: (2016)

Ending AIDS by 2030: the importance of an interlinked approach and meaningful youth leadership
por: Gleeson, Hayley S, et al.
Publicado: (2018)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Pembrolizumab provides long‐term survival benefits in advanced non‐small cell lung cancer: The 5‐year outcomes of the KEYNOTE‐024 trial
por: Li, Fengtan, et al.
Publicado: (2021)

The role of c-MET inhibitors in advanced hepatocellular carcinoma: now and future
por: Woo, Hyun Young, et al.
Publicado: (2020)

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials
por: Ozer, Muhammet, et al.
Publicado: (2023)

Commentary: Organ ARCs: Assessment and repair centers in transplantation as gateways to meaningful therapeutic interventions
por: Whitson, Bryan A., et al.
Publicado: (2020)

E-health: potential benefits and challenges in providing and accessing sexual health services
por: Minichiello, Victor, et al.
Publicado: (2013)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
por: Goudsmit, Ben F.J., et al.
Publicado: (2023)

COVID-19 appropriate behavior in India: Time to invest for the benefits in future
por: Gupta, Manoj Kumar, et al.
Publicado: (2021)

Triple combination therapy for pancreatic cancer remodels stroma and improves survival
por: Vázquez-Arreguín, Karina, et al.
Publicado: (2023)

Addressing epistemic injustice in HIV research: a call for reporting guidelines on meaningful community engagement
por: Pantelic, Marija, et al.
Publicado: (2022)

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
por: Chen, Jiang, et al.
Publicado: (2020)

Identifying hepatocellular carcinoma patients with survival benefits from surgery combined with chemotherapy: based on machine learning model
por: Hu, Jie, et al.
Publicado: (2022)

In silico trials of combination immuno-radiation for unresectable hepatocellular carcinoma
por: Mendiratta-Lala, Mishal, et al.
Publicado: (2023)

Theoretically meaningful models can answer clinically relevant questions
por: Evans, Nathan J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mrp6j0opr94sr9d498sg21msk